Alicia Herrero

932 total citations
34 papers, 471 citations indexed

About

Alicia Herrero is a scholar working on Infectious Diseases, Health Information Management and Geriatrics and Gerontology. According to data from OpenAlex, Alicia Herrero has authored 34 papers receiving a total of 471 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Infectious Diseases, 7 papers in Health Information Management and 6 papers in Geriatrics and Gerontology. Recurrent topics in Alicia Herrero's work include Electronic Health Records Systems (7 papers), Pharmaceutical Practices and Patient Outcomes (6 papers) and Patient Safety and Medication Errors (5 papers). Alicia Herrero is often cited by papers focused on Electronic Health Records Systems (7 papers), Pharmaceutical Practices and Patient Outcomes (6 papers) and Patient Safety and Medication Errors (5 papers). Alicia Herrero collaborates with scholars based in Spain, Canada and United Kingdom. Alicia Herrero's co-authors include Elena Villamañán, Rodolfo Álvarez-Sala, Ángel Manuel Iniesta, Juan R. Rey, Juan Caro‐Codón, José Luís Merino, Laura Rodríguez‐Sotelo, Lorena Martín‐Polo, Marcel Martínez‐Cossiani and Luis Gonzalez‐Valle and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and European Journal of Heart Failure.

In The Last Decade

Alicia Herrero

33 papers receiving 461 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alicia Herrero Spain 12 194 128 121 55 53 34 471
Jared Davis United States 6 46 0.2× 33 0.3× 61 0.5× 55 1.0× 33 0.6× 18 455
Sawai Singh Rathore United States 12 263 1.4× 113 0.9× 82 0.7× 70 1.3× 6 0.1× 44 499
Wally Omar United States 8 139 0.7× 77 0.6× 176 1.5× 65 1.2× 10 0.2× 11 424
Julia Snyder United States 5 151 0.8× 89 0.7× 139 1.1× 58 1.1× 2 0.0× 12 365
M.R. Holland United States 13 74 0.4× 31 0.2× 65 0.5× 46 0.8× 5 0.1× 41 623
Giuseppe Natoli Italy 12 74 0.4× 40 0.3× 34 0.3× 54 1.0× 37 0.7× 39 356
Rosa Malo de Molina Spain 13 126 0.6× 45 0.4× 89 0.7× 36 0.7× 11 0.2× 32 647
Eng Soo Yap Singapore 13 285 1.5× 253 2.0× 131 1.1× 94 1.7× 12 0.2× 58 759
Mickaël Basson France 5 28 0.1× 21 0.2× 50 0.4× 142 2.6× 36 0.7× 6 527
Murilo Guedes Brazil 13 48 0.2× 14 0.1× 30 0.2× 26 0.5× 6 0.1× 49 423

Countries citing papers authored by Alicia Herrero

Since Specialization
Citations

This map shows the geographic impact of Alicia Herrero's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alicia Herrero with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alicia Herrero more than expected).

Fields of papers citing papers by Alicia Herrero

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alicia Herrero. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alicia Herrero. The network helps show where Alicia Herrero may publish in the future.

Co-authorship network of co-authors of Alicia Herrero

This figure shows the co-authorship network connecting the top 25 collaborators of Alicia Herrero. A scholar is included among the top collaborators of Alicia Herrero based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alicia Herrero. Alicia Herrero is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Villamañán, Elena, Daniel Laorden, David Romero, et al.. (2023). Compassionate Use of Reslizumab in a Life-threatening Asthma Exacerbation. Journal of Investigational Allergology and Clinical Immunology. 34(1). 60–61. 3 indexed citations
2.
Caro‐Codón, Juan, Juan R. Rey, Antonio Buño Soto, et al.. (2021). Characterization of NT‐proBNP in a large cohort of COVID‐19 patients. European Journal of Heart Failure. 23(3). 456–464. 63 indexed citations
3.
Jiménez-Nàcher, Inmaculada, et al.. (2021). The role of the pharmacist within an immune-mediated inflammatory disease unit: Results of a survey of healthcare providers and patients.. Farmacia Hospitalaria. 45(6). 305–316.
4.
Caro‐Codón, Juan, Juan R. Rey, Antonio Buño Soto, et al.. (2021). Characterization of myocardial injury in a cohort of patients with SARS-CoV-2 infection. Medicina Clínica. 157(6). 274–280. 9 indexed citations
5.
Caro‐Codón, Juan, Gregory Y.H. Lip, Juan R. Rey, et al.. (2021). Prediction of thromboembolic events and mortality by the CHADS2 and the CHA2DS2-VASc in COVID-19. EP Europace. 23(6). 937–947. 12 indexed citations
6.
Villamañán, Elena, Alicia Herrero, Rodolfo Álvarez-Sala, & Santiago Quirce. (2020). Multidisciplinary Severe Asthma Management: The Role of Hospital Pharmacists in Accredited Specialized Adult Asthma Units in Spain. Journal of Investigational Allergology and Clinical Immunology. 30(4). 305–306. 3 indexed citations
7.
Rey, Juan R., Juan Caro‐Codón, Sandra Rosillo, et al.. (2020). Heart Failure in COVID-19 Patients: Prevalence, Incidence and Prognostic Implications. European Journal of Heart Failure. 22(12). 2205–2215. 151 indexed citations
8.
Villamañán, Elena, et al.. (2019). Persistence of biological agents over an eight-year period in rheumatoid arthritis and spondyloarthritis patients.. SHILAP Revista de lepidopterología. 43(1). 24–30. 5 indexed citations
9.
Villamañán, Elena, Inmaculada Jiménez-Nàcher, Francisco Moreno, et al.. (2019). Cost evolution of biological drugs in rheumatoid arthritis patients in a tertiary hospital: Influential factors on price. Reumatología Clínica. 17(6). 335–342. 3 indexed citations
10.
Villamañán, Elena, Inmaculada Jiménez-Nàcher, Francisco Moreno, et al.. (2018). Cost evolution of biological agents for the treatment of spondyloarthritis in a tertiary hospital: influential factors in price. International Journal of Clinical Pharmacy. 40(6). 1528–1538. 6 indexed citations
11.
Villamañán, Elena, et al.. (2015). New technologies as a strategy to decrease medication errors: how do they affect adults and children differently?. World Journal of Pediatrics. 12(1). 28–34. 13 indexed citations
12.
Villamañán, Elena, et al.. (2015). Juego de patentes. Sobre medicamentos genéricos y biosimilares. Revista de Calidad Asistencial. 31(2). 99–105. 2 indexed citations
13.
Ramı́rez, Elena, Eduardo López‐Granados, Alberto M. Borobia, et al.. (2014). Symptomatic thromboembolic events in patients treated with intravenous-immunoglobulins: Results from a retrospective cohort study. Thrombosis Research. 133(6). 1045–1051. 48 indexed citations
14.
Villamañán, Elena, et al.. (2013). Análisis de las preferencias de los profesionales sanitarios respecto a la prescripción electrónica de tratamientos farmacológicos en pacientes hospitalizados. Revista de Calidad Asistencial. 28(5). 313–320. 3 indexed citations
15.
Villamañán, Elena, et al.. (2013). Potential medication errors associated with computer prescriber order entry. International Journal of Clinical Pharmacy. 35(4). 577–583. 35 indexed citations
16.
Ramı́rez, Elena, Rosa Gómez-Gil, Alberto M. Borobia, et al.. (2012). Improving linezolid use decreases the incidence of resistance among Gram-positive microorganisms. International Journal of Antimicrobial Agents. 41(2). 174–178. 13 indexed citations
17.
Ramı́rez, Elena, Julio García‐Rodríguez, Alberto M. Borobia, et al.. (2011). Use of antifungal agents in pediatric and adult high-risk areas. European Journal of Clinical Microbiology & Infectious Diseases. 31(3). 337–347. 11 indexed citations
18.
Villamañán, Elena, Alicia Herrero, & Rodolfo Álvarez-Sala. (2010). Prescripción electrónica asistida como nueva tecnología para la seguridad del paciente hospitalizado. Medicina Clínica. 136(9). 398–402. 13 indexed citations
19.
Herrero, Alicia, et al.. (2002). Documentos de consentimiento informado en atención primaria. Revista de Calidad Asistencial. 17(6). 325–330. 1 indexed citations
20.
Pérez-Ruiz, Fernando, et al.. (1995). High prevalence of undetected carpal tunnel syndrome in patients with fibromyalgia syndrome.. PubMed. 22(3). 501–4. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jared Davis Breakdown of academic impact, for papers by Sawai Singh Rathore Breakdown of academic impact, for papers by Wally Omar Breakdown of academic impact, for papers by Julia Snyder Breakdown of academic impact, for papers by M.R. Holland Breakdown of academic impact, for papers by Giuseppe Natoli Breakdown of academic impact, for papers by Rosa Malo de Molina Breakdown of academic impact, for papers by Eng Soo Yap Breakdown of academic impact, for papers by Mickaël Basson Breakdown of academic impact, for papers by Murilo Guedes
Rankless by CCL
2026